Moneycontrol
HomeNewsPodcastCoronavirus Essential podcast | Health ministry warns against N95 mask use; data claims 18 crore Indians may be immune to COVID-19

Coronavirus Essential podcast | Health ministry warns against N95 mask use; data claims 18 crore Indians may be immune to COVID-19

Tune in to Coronavirus Essential podcast with Sakshi Batra for all the top news on the ongoing pandemic.

Moneycontrol News
July 21, 2020 / 19:07 IST
Story continues below Advertisement
Remove Ad

Dr Rajiv Garg, the Director-General of Health Services has warned states and union territories that N-95 masks with respiratory valves do not help prevent the spread of coronavirus. In a letter dated July 20, he urged the authorities to revisit the advisory on the use of home-made masks.

Story continues below Advertisement
Remove Ad

Meanwhile, data from Thyrocare's antibody tests show Indians may already have immunity to COVID-19, as many have recovered without showing major symptoms. The data showed that nearly 15 percent of those tested had antibodies against SARS-Cov2, which causes COVID-19.

Tune in to Coronavirus Essential podcast with Sakshi Batra for all the top news on the ongoing pandemic.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
 View more
+ Show
Moneycontrol News
first published: Jul 21, 2020 07:07 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin telegram youtube
Trending Topics
Sensex Today Tata Capital IPO GMP Bihar Election Date Cuttack violence CJI Gavai News Tata Trusts Jaipur Hospital Fire Donald Trump TCS Layoffs Darjeeling landslide
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.